Zhongyang Shen

Zhongyang Shen

Organ Transplantation Center, The First Central Hospital Of Tianjin, Tianjin, China (Mainland).

Direct Impact

Concepts for which Zhongyang Shen has direct influence:

liver transplantation
hepatic malignancies
tumor recurrence
gene therapy
hepatocellular carcinoma
mediated adjuvant

External impact

Concepts related to the work of other authors for which Zhongyang Shen has influence:

liver transplantation
hepatocellular carcinoma
ischemic-type biliary lesions
gastric cancer
adipocyte differentiation
recurrent hcc
combined heart

Prominent publications by Zhongyang Shen

KOL-Index: 63 BACKGROUND The aim of this study was to classify ischemia-type biliary lesions after liver transplantation according to their imaging findings and severity of clinical manifestations and to analyze the relationship between such classification and prognosis. MATERIAL AND METHODS We collected clinical data of patients with ischemia-type biliary lesions (ITBL) after liver transplantation in the ...
Known for
Prognosis Severe | Anastomotic Biliary Obstruction | Itbl Liver | Postoperative Survival Time
KOL-Index: 48 Objective To discuss the surgical strategy for children with complex congenital heart disease (CHD) and end-stage liver disease (ESLD). Methods We reported two cases of pediatric liver transplantation in patients with complex CHD and ESLD. Medical data including operation procedure, ICU management and outcomes were reviewed retrospectively. Also we reviewed the literature on the topic of ...
Known for
Open-Heart Surgery | Operative Liver | Unroofed Coronary Sinus Syndrome | Acute Cardiac Dysfunction
KOL-Index: 44 Objective To compare long-term outcome of primary liver transplantation and salvage liver transplantation in treating patients with primary liver cancer, and discuss the clinical feasibility of salvage liver transplantation. Methods We retrospectively analyzed the clinical data of 1 420 patients with primary liver cancer, including 170 cases treated with salvage liver transplantation and 1 ...
Known for
Transplantation Center | Major Options | 1 250 | Lower Long-Term Survival Rates
KOL-Index: 28 Long non-coding RNAs (lncRNAs) are associated with occurrence and development of tumors. Enhancer RNA (eRNA) is a special type of lncRNAs produced from transcription of enhancer elements. The function of eRNAs in tumors have elicited significant attention recently. However, the clinical significance and role of eRNAs in hepatocellular carcinoma (HCC) has not been fully explored. The current ...
Known for
Rna Erna | Expressed Tumor | Prkcd Survival
KOL-Index: 21 OBJECTIVES: The present study aimed to investigate the dynamic change of α cells and β cells, and their ratios in prediabetes and type 2 diabetes in the Chinese population. METHODS: Pancreata from 27 nondiabetic (ND), 8 prediabetic (PreD), and 19 type 2 diabetic (T2D) organ donors were subjected to immunofluorescence staining with insulin and glucagon. RESULTS: The β to α ratio in islets ...
Known for
Islet Percentage | Dynamic Cells | Diabetes Chinese
KOL-Index: 10 β cells suffer from hypoxia due to the rapid metabolic rate to supply insulin production. Mechanistic study of β cell survival under hypoxia may shed light on the β cell mass loss in type 2 diabetes mellitus (T2DM). Here, we found that the expressions of LC3 and p62/SQSTM1, two key autophagy regulators, were significantly higher in β cells than that in non-β endocrine cells in both ...
Known for
Foxo1 Islets | -Diabetic T2dm Pancreases | Β Mass Loss | Immunofluorescence Staining
KOL-Index: 6 Marked improvement in the prognosis for patients with liver cancer who undergo liver transplantation has been achieved as a result of advances in liver transplantation techniques. Given the current shortage of organs in China, a favorable long-term survival rate might be achieved with rigorous selection of suitable patients and therefore benefit society the most. Further study of the ...
Known for
Benefit Liver | Transplantation Techniques
KOL-Index: 4 OBJECTIVE: To summarize the experience of living donor liver transplantation using cryopreserved iliac vein for middle hepatic vein reconstruction. METHODS: Between July 2006 and June 2009, right liver transplantation without middle hepatic vein was performed in 37 cases of 85 patients undergoing living donor liver transplantation; of 37 cases, 30 received middle hepatic vein reconstruction ...
Known for
1 Congenital Hepatic Fibrosis | 2 Wilsons | 3 Females | 0-4 Degrees Mixed Antibiotics
KOL-Index: 2

Organ Transplantation Center, The First Central Hospital of Tianjin, Tianjin, China (mainland).

https://www.g2.com/products/key-opinion-leaders-kols/reviews https://www.bbb.org/us/fl/doral/profile/data-analytics/key-opinion-leaders-0633-92023858 https://www.trustpilot.com/review/keyopinionleaders.com https://www.yelp.com/biz/key-opinion-leaders-miami

© 2022 - Key Opinion Leaders -
Key Opinion Leaders, LLC ,
2025 NW 102 Avenue, Suite 111 Doral , FL   33172